Sartorius Stedim Biotech SA (STDM)

Currency in EUR
220.70
-2.30(-1.03%)
Closed·
STDM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
217.40223.00
52 wk Range
148.75239.80
Key Statistics
Prev. Close
220.7
Open
223
Day's Range
217.4-223
52 wk Range
148.75-239.8
Volume
59.88K
Average Volume (3m)
70.65K
1-Year Change
11.38%
Book Value / Share
41.48
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STDM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
243.00
Upside
+10.10%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Sartorius Stedim Company Profile

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has collaboration with Bio Usawa Biotechnology, Ltd. focus on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.

Employees
10134
Market
France

Compare STDM to Peers and Sector

Metrics to compare
STDM
Peers
Sector
Relationship
P/E Ratio
81.1x31.6x−0.6x
PEG Ratio
1.331.260.00
Price/Book
5.3x4.5x2.6x
Price / LTM Sales
7.3x4.8x3.3x
Upside (Analyst Target)
11.5%13.3%40.0%
Fair Value Upside
Unlock−4.0%3.2%Unlock

Analyst Ratings

11 Buy
2 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 243.00
(+10.10% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy250.00+13.28%230.00Maintain07/01/2026
Bernstein SocGen Group
Buy245.00+11.01%248.00Maintain17/12/2025
RBC Capital
Buy240.00+8.74%230.00Maintain22/10/2025
Barclays
Buy230.00+4.21%240.00Maintain21/10/2025
HSBC
Buy230.00+4.21%210.00Maintain17/10/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.71%
Dividend Yield
0.31%
Industry Median 1.33%
Annualised payout
0.69
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 16, 2025
EPS / Forecast
0.94 / 0.9816
Revenue / Forecast
705.70M / 696.97M
EPS Revisions
Last 90 days

People Also Watch

108.900
VIRI
-3.54%
71.65
AMUN
+0.35%
68.86
EUFI
-0.20%
68.35
ERMT
-1.16%
27.44
BVI
-0.58%

FAQ

What Is the Sartorius Stedim (STDM) Share Price Today?

The live Sartorius Stedim share price today is 220.70

What Stock Exchange Does Sartorius Stedim (STDM) Trade On?

Sartorius Stedim is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Sartorius Stedim?

The stock symbol (also called a 'ticker') for Sartorius Stedim is "STDM."

Does Sartorius Stedim Pay Dividends? What’s The Current STDM Dividend Yield?

Yes, STDM Pays Dividends to its Shareholders. The current Sartorius Stedim dividend yield is 0.31%.

What Is the Current Sartorius Stedim Market Cap?

As of today, Sartorius Stedim market capitalisation is 21.47B.

What Is Sartorius Stedim's (STDM) Earnings Per Share (TTM)?

The Sartorius Stedim EPS is currently 2.71 (Trailing Twelve Months).

When Is the Next Sartorius Stedim Earnings Date?

Sartorius Stedim's next earnings report will be released on 03 Feb 2026.

Is STDM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sartorius Stedim moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sartorius Stedim Stock Split?

Sartorius Stedim has split 7 times. (See the STDM stock split history page for full effective split date and price information.)

How Many Employees Does Sartorius Stedim Have?

Sartorius Stedim has 10134 employees.

What is the current trading status of Sartorius Stedim (STDM)?

As of 09 Jan 2026, Sartorius Stedim (STDM) is trading at a price of 220.70, with a previous close of 220.70. The stock has fluctuated within a day range of 217.40 to 223.00, while its 52-week range spans from 148.75 to 239.80.

What Is Sartorius Stedim (STDM) Price Target According to Analysts?

The average 12-month price target for Sartorius Stedim is EUR243, with a high estimate of EUR275 and a low estimate of EUR218. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +10.10% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.